BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 22039239)

  • 21. Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma.
    Blom DJ; Luyten GP; Mooy C; Kerkvliet S; Zwinderman AH; Jager MJ
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1865-72. PubMed ID: 9286277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
    All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JARID1B protein expression and prognostic implications in uveal melanoma.
    Radberger P; Radberger A; Bykov VJ; Seregard S; Economou MA
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4442-9. PubMed ID: 22669717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions.
    Gambichler T; Grothe S; Rotterdam S; Altmeyer P; Kreuter A
    Am J Clin Pathol; 2009 Jun; 131(6):782-7. PubMed ID: 19461083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression predicts metachronous pulmonary metastasis and poor survival in patients with hepatoblastoma.
    Tsukada M; Wakai T; Matsuda Y; Korita PV; Shirai Y; Ajioka Y; Hatakeyama K; Kubota M
    J Pediatr Surg; 2009 Aug; 44(8):1522-8. PubMed ID: 19635299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
    Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression and modulation of CEACAM1 and tumor cell transformation.
    Fiori V; Magnani M; Cianfriglia M
    Ann Ist Super Sanita; 2012; 48(2):161-71. PubMed ID: 22751559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, pathologic, and imaging features and biological markers of uveal melanoma.
    Rashid AB; Grossniklaus HE
    Methods Mol Biol; 2014; 1102():397-425. PubMed ID: 24258990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics in uveal melanoma.
    Ramasamy P; Murphy CC; Clynes M; Horgan N; Moriarty P; Tiernan D; Beatty S; Kennedy S; Meleady P
    Exp Eye Res; 2014 Jan; 118():1-12. PubMed ID: 24056206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eyelids metastases from uveal melanoma: clinical and histopathologic features of two cases and literature review.
    Martel A; Oberic A; Moulin A; Zografos L; Hamedani M
    Eye (Lond); 2019 May; 33(5):767-771. PubMed ID: 30560912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic parameters in uveal melanoma: a review.
    Mooy CM; De Jong PT
    Surv Ophthalmol; 1996; 41(3):215-28. PubMed ID: 8970236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of morphometric features and the callender classification in uveal melanomas.
    Coleman K; Baak JP; van Diest PJ; Mullaney J
    Ophthalmology; 1996 Oct; 103(10):1634-41. PubMed ID: 8874437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CEACAM1: Expression and Role in Melanocyte Transformation.
    Turcu G; Nedelcu RI; Ion DA; Brînzea A; Cioplea MD; Jilaveanu LB; Zurac SA
    Dis Markers; 2016; 2016():9406319. PubMed ID: 27642217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic factors for uveal melanoma].
    Amiryan AG; Saakyan SV
    Vestn Oftalmol; 2015; 131(1):90-95. PubMed ID: 25872392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) in Human Malignancies.
    Calinescu A; Turcu G; Nedelcu RI; Brinzea A; Hodorogea A; Antohe M; Diaconu C; Bleotu C; Pirici D; Jilaveanu LB; Ion DA; Badarau IA
    J Immunol Res; 2018; 2018():7169081. PubMed ID: 30406153
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.